课题基金 / 基金详情

A SINGLE ARM, OPEN-LABEL PILOT TRIAL OF THE SAFETY AND IMMUNOGENICITY OF A QUADR

A SINGLE ARM, OPEN-LABEL PILOT TRIAL OF THE SAFETY AND IMMUNOGENICITY OF A QUADR
Quadr 安全性和免疫原性的单臂、开放标签试点试验
批准号：
7951594
负责人：
RONALD T. MITSUYASU
金额：
$9.4万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
项目状态：
已结题
起止时间：
2009-04-01 至 2009-11-30
来源：
https://reporter.nih.gov/project-details/7951594
关键词：
AntibodiesClinical ResearchComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantHuman Papilloma Virus VaccineHuman PapillomavirusInstitutionRecombinant VaccinesResearchResearch PersonnelResourcesSafetySourceUnited States National Institutes of HealthUpper armimmunogenicitymenopen labelpilot trial

项目摘要

项目成果

RONALD T. MITSUYASU的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 评估四价HPV重组疫苗在HIV感染男性中的安全性和耐受性。 评估6、11、16和18型四价HPV疫苗在基线抗体阴性受试者中的免疫原性。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To assess the safety and tolerability of the quadrivalent HPV recombinant vaccine in HIV-infected men. To assess the immunogenicity of the quadrivalent HPV vaccine for types 6, 11, 16 and 18 in subjects who are antibody-negative at baseline.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
South American Prevention of HIV Research Training Program (SAPHIR)
South American Prevention of HIV Research Training Program (SAPHIR)
海外基金